TLDR A woman experienced sudden hair graying and loss after a COVID-19 vaccine, which improved with treatment.
A 39-year-old woman experienced sudden graying and diffuse hair loss, diagnosed as Marie Antoinette syndrome, following the Pfizer/BioNTech COVID-19 vaccine. The condition worsened after the second dose but improved significantly with oral prednisone and topical clobetasol treatment, showing almost complete hair regrowth and partial repigmentation after 6 weeks. This case, along with a review of 14 similar cases, suggests a potential link between mRNA COVID-19 vaccines and alopecia areata, particularly in females, with a need for further studies on long-term outcomes.
1 citations
,
September 2022 in “Journal of The American Academy of Dermatology” Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.
1 citations
,
January 2022 in “Dermatology Reports” Many people with hair loss, especially those with telogen effluvium and alopecia areata, often have a sensitive scalp.
2 citations
,
September 2021 in “JAAD case reports” Dupilumab helped a woman with severe hair loss regrow her hair quickly and maintain it for six months after stopping treatment.
6 citations
,
January 2019 in “Indian Journal of Dermatology” About 12% of children in Kota, Rajasthan, experience hair loss, mainly due to fungal infections, with early treatment advised to prevent worsening.
36 citations
,
May 2011 in “Dermatologic therapy” No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.
109 citations
,
May 2011 in “Dermatologic Therapy” Alopecia areata is a type of hair loss that can lead to complete baldness, often associated with other autoimmune conditions, and half of the cases may see hair return within a year.
